596TiP Phase I first-in-human study of ABBV-151 as monotherapy or in combination with budigalimab in patients with locally advanced or metastatic solid tumours.
Saved in:
| Title: | 596TiP Phase I first-in-human study of ABBV-151 as monotherapy or in combination with budigalimab in patients with locally advanced or metastatic solid tumours. |
|---|---|
| Authors: | Powderly, J.1 (AUTHOR), Shimizu, T.2 (AUTHOR), Lorusso, P.3 (AUTHOR), Razak, A.4 (AUTHOR), Miller, K.D.5 (AUTHOR), Balar, A.V.6 (AUTHOR), Bruix, J.7 (AUTHOR), Michel, L.S.8 (AUTHOR), Blaney, M.9 (AUTHOR), Guan, X.10 (AUTHOR), Lacy, S.11 (AUTHOR), Lally, S.9 (AUTHOR), Lambert, S.9 (AUTHOR), Leibman, R.9 (AUTHOR), Vosganian, G.9 (AUTHOR), Golan, T.12 (AUTHOR), Tolcher, A.13 (AUTHOR) |
| Source: | Annals of Oncology. 2020 Supplement 4, Vol. 31, pS499-S499. 1p. |
| Database: | Academic Search Ultimate |
| ISSN: | 09237534 |
|---|---|
| DOI: | 10.1016/j.annonc.2020.08.710 |
